Navigation Links
Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
Date:9/11/2007

Generic Erosion of Zocor and Lipitor Will Cause Market Share of Statins to Drop Nearly 40% by 2016, According to a New Report from Decision Resources

WALTHAM, Mass., Sept. 11 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the market entry of novel angiogenic agents, including a future blockbuster drug from Genzyme, could revolutionize symptomatic treatment of peripheral arterial disease (PAD).

The new Pharmacor report Peripheral Arterial Disease finds that Genzyme's HIF-1 alpha therapy for PAD patients with intermittent claudication, which could reach the market as early as 2010, will garner sales of $1.5 billion in 2016 in the world's major pharmaceutical markets. Experts are optimistic about the market entry of novel angiogenic therapies, which act by generating new blood vessels in the legs and are the first agents to be developed as disease- modifying therapies for PAD. Although numerous studies will be required to establish the efficacy and safety of angiogenic products, physicians are hopeful these pioneering, PAD-specific therapies will be effective in treating the intermittent claudication and critical limb ischemia patient segments.

The report also finds that although statins will continue to dominate the PAD prescription landscape, the U.S. patent expiries of Merck's Zocor in 2006 and Pfizer's Lipitor in 2010 will cause total statin market share to drop from 58% in 2006 to 21% in 2016. The U.S. patent expiry of Zocor will prompt a rapid and extensive shift in prescribing to generic equivalents from 2007 onward as third-party payers remove the brand from formularies.

"Patient-share growth will be fastest for generic Zocor, which will overtake Lipitor for prescriptions in the majority of newly diagnosed PAD patients who may be unable to afford the high co-payments associated with Lipitor," said Mary Argent-Katwala, Ph.D., analyst at
'/>"/>

SOURCE Decision Resources
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Novel PCR Enhancing Factor Improves Performance of Pfu DNA Polymerase
2. High-Fidelity PCR with a Novel Polymerase Mixture
3. Challenge the Performance of Your Hot-Start PCRs with FastStart Taq DNA Polymerase and the Novel FastStart High Fidelity PCR System
4. Combine High Yield, Great Accuracy and the Prevention of Carry-over Contamination by Using the Novel Expand High FidelityPLUS PCR System
5. Novel MicroRNA Array Technology for Sensitive miRNA Profiling
6. A Novel Process for Gene Expression Profiling of Rat and Mouse Tissues from Formalin-Fixed Paraffin-Embedded Sections Using Microarrays
7. Use of Novel FlashPlate Technology to Measure cAMP Accumulation in Chinese Hamster Ovary Cells Expressing Human -2 Adrenoreceptors
8. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
9. Novel Bonding Chemistry Imparts Enhanced Polar Selectivity to TSK-GEL ODS-100V Reversed Phase Columns
10. Unique Surface Treatment of Novel TSK-GEL ODS Columns Provide Separation of Aqueous and Fat Soluble Vitamins
11. Life-sciences conference to feature novel research with clinical potential

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... 2009 Senomyx, Inc. (Nas...ry taste receptor-based technologies to discover n...d ingredient supply industries, today provided a c... the third quarter ended September 30, 2009. Reve...09, compared to $4.0 million for the third quarter...
(Date:11/5/2009)...ewswire/ -- SpineSmith Partners has signed an init...unique scaffold that mimics the structure of natur...al commercial products by SpineSmith,s Research an... GenOsteo scaffold represents a significant advanc...l environment for the delivery of adult stem cells...
(Date:11/5/2009)...afety specialty firm BioSoteria announced that its...d the Certified Professional in Learning and Perfo...Society for Training and Development (ASTD) Certif... fifteen years of medical communications and healt...the development of the company,s online pharmacovi...
(Date:11/5/2009)... Sanders brings a new look to Pro Repro , ...09 -- Professional Reprographics, Orange County&rs...ased to present Brooke Sanders to the company. Bro...ist. The addition of Brooke to the company represe...ional Reprographics., , ,Brooke brings with her ov...
Breaking Biology Technology:SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 4
...n Tuesday, Michigan voters,were asked to support M...rate medical research and develop new stem cell tr...ernational Society for Stem Cell,Research (ISSCR),...l,researchers, along with other leading scientists... The vote was 53% in favor and 47% opposed to,Prop...
...Environmental,Tectonics Corporation,s (Amex: ETC ...sion recently hired Mr. David Steimle as Director ...e for expanding market awareness for,the BARA-MED(...y,manufacturer of a time proven computerized monop...ith eighteen years in the medical industry,twelve ...
... Misonix, Inc.,(Nasdaq: MSON ), a developer of mi...ogy, which in Europe is used for the ablation of c...ons, has entered into a new, three,year, exclusive...e Medical,BV, based in Rotterdam, The Netherlands,...ic Surgical Aspirator, the BoneScalpel(TM) Ultraso...
Other Biology Technology:International Society for Stem Cell Research Applauds Outcome of Proposal 2 Advancing Stem Cell Research 2Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division 2Environmental Tectonics Corporation Announces Staff Addition to Its BioMedical Systems Division 3Misonix Announces New Distribution Agreement for The Netherlands 2Misonix Announces New Distribution Agreement for The Netherlands 3
(Date:11/4/2009)...009 Childhood obesity in the United States is rea...rth of advertising on daytime and prime time telev...g questions about the role television plays in obe...e Journal of Nutrition Education and Behavior ex...t be a large contributor to the problem. , Resea...
(Date:11/4/2009)...PRNewswire-FirstCall/ -- Quest Diagnostics Incorpo...of diagnostic testing, information and services, a...r 30, 2009, income from continuing operations rose... $160 million, or $0.81 per diluted share, for the...ults were reduced by a $0.03 per share charge asso...
(Date:11/4/2009)...ewswire-FirstCall/ -- BIO-key International, Inc. ...ed biometric identification software is showcasing...TXPO conference being held at the New Orleans Conv...l provide hands-on product demonstrations of its s... #424. Also, at 5 PM on Monday, October 26, Peter ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2Prostate Cancer Active Surveillance Protocol Clinical Trial Conducted by NorthShore University HealthSystem 48933 1Prostate Cancer Active Surveillance Protocol Clinical Trial Conducted by NorthShore University HealthSystem 48933 2Prostate Cancer Active Surveillance Protocol Clinical Trial Conducted by NorthShore University HealthSystem 48933 3Prostate Cancer Active Surveillance Protocol Clinical Trial Conducted by NorthShore University HealthSystem 48933 4American Academy of Hospice and Palliative Medicine Leader Touts Quality Cost Benefits of Palliative Care for Healthcare Reform 48931 1American Academy of Hospice and Palliative Medicine Leader Touts Quality Cost Benefits of Palliative Care for Healthcare Reform 48931 2TechNet Urges Swift U S Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell 12629 1TechNet Urges Swift U S Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell 12629 2TechNet Urges Swift U S Senate Approval of FCC Nominees Julius Genachowski and Robert McDowell 12629 3
... they are nothing but a cosmetic nuisance. But som...anocytes start dividing abnormally to form a deadl...in 65 Americans born this year will be diagnosed w... , Scientists know that 30 percent of all melanoma...les contain cancer-causing mutations. What scienti...
...ts of mythological beliefs. Some cultures prize th...es. Others have used them as dagger handles or goo... removes some of the mystique by explaining how th...ted tip. , Scientists have discovered new details ...and the role those materials play in the developme...
...human genome are thousands of previously unknown o...f breast cancer is driven by estrogen, new researc...revealed. , In the October issue of Nature Geneti...ap of the molecular "control panels" -- stretches ...he cells, estrogen receptor, the master regulator ...
Other Biology News:Why don't all moles progress to melanoma? 2Why don't all moles progress to melanoma? 3Scientists crack rhino horn riddle 2Molecular atlas provides new tool for understanding estrogen-fueled breast cancer 2Molecular atlas provides new tool for understanding estrogen-fueled breast cancer 3
...te readers combines reagent dispensing with fluore... affordable, easy-to-use platform for the complete...dular design and adaptability of the Infinite 200 ...ochromator (M200) or filter (F200) system and allo...
RNA 6000 Nano Chip Kit from Agilent Technologies
The Discovery Series PDQuest Version Upgrade from Bio-Rad
...igh Quality, Functionally-Validated, Ion Channel C...g a critical role in nerve and muscle function and... the heart. Drugs that modulate ion channels have ...uropathic pain, cardiac arrhythmia, hypertension, ...
Biology Products: